Innovation

CPL-Pharma: Unlock your potential

We accelerate the journey from molecule to market by delivering end-to-end CDMO solutions, ensuring faster, safer, and smarter access to life-changing therapies worldwide.

0 +

Years of Excellence

100 +

Global Clients

0 +

Countries Served

Who We Are

About Us

At the forefront of pharmaceutical innovation, CPL Pharma stands as a trusted API CDMO partner, committed to helping global healthcare companies bring life-saving therapies to patients faster, safer, and smarter. Our science-led approach enables us to drive innovation from discovery to delivery, ensuring seamless support across every stage of drug development and manufacturing.

With strong regulatory expertise, state-of-the-art facilities, and a collaborative mindset, we go beyond manufacturing—we co-create success with our partners. By combining advanced technologies, sustainable practices, and a customer-first approach, we deliver reliable, high-quality solutions that empower growth and transform healthcare outcomes worldwide.

Vision

To be recognized as a global leader in API and CDMO services, delivering breakthrough healthcare solutions through science, innovation, and operational excellence.

Values

We are driven by Integrity, Innovation, Sustainability, and Customer-Centric Collaboration—principles that guide our every decision and partnership.

Promise

With global delivery capabilities and a collaborative mindset, we ensure long-term partnerships built on trust, innovation, and a shared commitment to success.

What We Do

Our Services – API & CDMO Offering

End-to-End Development

Seamless support from preclinical research to full-scale commercialization.

Innovative Manufacturing

Advanced technologies for APIs, biologics, and complex generics.

Regulatory Expertise

Strict compliance with USFDA, EMA, WHO, MHRA, PMDA, and more.

Scalable Solutions

Digitally integrated Industry 4.0 facilities with AI-enabled systems.

Facilities

Our World-Class Facilities

Dahej Facility

Greenfield, state-of-the-art DCS-controlled API manufacturing unit ensuring purity, consistency, and sustainability.

Ankleshwar 1 & 2

Accredited by USFDA, PMDA Japan, EDQM Europe, WHO Geneva, ANVISA Brazil.

R&D Facility

Located at CSBU R&D (2nd floor), with 150+ scientists and advanced labs in synthetic chemistry, analytical studies, and process engineering.

Leadership Team

The Leaders Behind Innovation

Our executive team brings decades of scientific, operational, and strategic expertise to drive CPL Pharma’s

Biswajit Mitra

Chief Mentoring Officer

Mr Mitul Dave

Chief Operating Officer

Vikas Vij

President Mkt API & CDMO business

Process

Cadila’s CDMO Project Management process

Project Alignment

Coordinating multiple CDMO projects (e.g., Research, Process development, Analytical method validation, Scale-up) to ensure alignment with drug (Substance & Product) development strategy and timelines.

Regulatory Compliance

Maintaining adherence to all relevant regulatory guidelines (USFDA, EMA, EDQM, ICH) throughout the drug development process, including documentation and quality control procedures.

Risk Management

Identifying potential risks associated with manufacturing processes, raw materials, and analytical methods, and implementing mitigation strategies to minimize their impact.

Resource Management

Effectively allocating personnel, equipment, and budget across different CDMO projects to optimize efficiency, Cost effectiveness and meet deadlines.

Quality Assurance

Implementing robust quality systems to ensure the consistent production of high-quality drug Substance and products, including thorough validation and quality control procedures

Developing program plans

Creating a comprehensive program roadmap outlining key milestones, timelines, deliverables, and resource requirements for each CDMO project.

Stakeholder management

Communicating effectively with cross-functional teams (R&D, regulatory affairs, quality assurance) to ensure alignment and address potential issues.

Progress monitoring

Tracking project progress against the program plan, identifying potential delays, and taking corrective actions as needed.

Change management

Managing changes to the program scope or requirements, ensuring proper documentation and communication with all stakeholders

Reporting & analysis:

Providing regular updates on program status, key metrics, and performance indicators to senior management.

Research & Development

Driving Science, Delivering Solutions

Our R&D is powered by more than 150 scientists with expertise in:

Engineering

Manufacturing Technologies

State-of-the-art Technology from Glatt for Granulation, Coating and ACG for Capsule filling provides consistent quality and high through put

Manufacturing Equipment & Capacity (Gujarat)

Our Gujarat facility is designed to meet global regulatory standards, delivering consistent quality and efficiency across production lines. With advanced automation, it handles large-scale output while staying flexible for multiple dosage forms, supported by strict quality assurance.

The plant also emphasizes sustainability, innovation, and strong R&D support. Backed by modern infrastructure and skilled teams, we adapt quickly to market needs, making us a trusted partner for both domestic and international markets.

Manufacturing Capacity
(Oral Solid Dosage)
Manufacturing Capacity
(Injectable)
Dosage Annual Capacity
Tablets 15 Billion
Capsules 1 Billion
Area Lines
Granulation 7 lines
Compression 14 lines
Coating 9 lines
Visual Inspection 3 lines
Capsulation 2 lines
Packing 18 lines
Dosage Annual Capacity
Ampoule 45 Million
Vial 65 Million
Lyophilized 2.5 Million
PFS 10 Million
rDNA (Vials) 15 Million
Area Lines
Ampoule 1 line
Vial Filling 3 lines
Packing 3 lines
rDNA 1 line
*Capacity calculated are 3 shift basis

Sustainable Future

Sustainability & ESG Commitment

Sustainability is core to CPL Pharma’s operations. From eco-conscious manufacturing to energy-efficient R&D practices, our ESG commitment ensures we contribute positively to society, healthcare, and the environment.

Standards

Regulatory Accreditations

Contact Us

Let’s Partner for Innovation

Whether you are looking for end-to-end API development, CDMO services, or research collaboration—our team is here to help.